Virax Biolabs Group Limited logo

Virax Biolabs Group Limited

VRAX | NASDAQ
Chart Builder DCF Calculator
$2.50
+$0.19 (+8.23%)
At close: Sep 22, 2026, 4:00 PM ET
$2.50
$0 (0.00%)
After-hours: Sep 22, 2026, 7:30 PM ET

Market Data

Market Cap
$431.1K
Enterprise Value
$-5.67M
Beta
1.36
Average Volume
1.76M
Shares Outstanding (Diluted)
604.66K
Shares Change YoY
575.58%
Institutional Ownership
9.25%
Exchange
NASDAQ
ISIN
KYG9495L1335

Price Performance

Price Change 1M
-26.0%
Price Change 3M
-40.3%
Price Change 6M
-50.1%
Price Change YTD
-75.9%
Price Change 1Y
-85.1%
Price Change 3Y
-97.4%
Price Change 5Y
-99.9%
1M CAGR (ann.)
-22.5%
1Y CAGR (ann.)
-85.7%
5Y CAGR (ann.)
N/A
All-Time CAGR
-83.8%

Valuation

PE Ratio
-0.14
Forward PE
N/A
PEG Ratio
-0.00
Forward PEG
0.00
PS Ratio
34.70
Forward PS
107.80
PB Ratio
0.06
P/FCF Ratio
-0.09
P/Adj. FCF Ratio
-0.08
P/OCF Ratio
-0.12
EV/Sales
-456.63
EV/EBIT
0.89
EV/EBITDA
0.94
EV/FCF
1.13
Earnings Yield
-722.9%
FCF Yield
-1169.3%
Adj. FCF Yield
-1187.6%

Financial Health

Net Cash
$6.49M
Total Debt
$414.39K
Cash & Short-Term Investments
$6.52M
Total Assets
$8.32M
Current Ratio
9.97
Quick Ratio
9.90
Debt / Equity Ratio
0.05
Debt / EBITDA
-0.07
Debt / FCF
-0.08
OCF / Debt
-11.55
Interest Coverage
-96.86
Altman Z-Score
-6.37
Piotroski F-Score
2

Margins & Profitability

Gross Profit Margin
-1480.5%
Operating Profit Margin
-51515.2%
EBITDA Margin
-56151.4%
Net Profit Margin
-52473.3%
FCF Margin
-40576.6%
Adj. FCF Margin
-41211.8%
SBC / Revenue
929.4%
SBC Impact (per share)
-1.6%

Returns

Return on Assets
-88.4%
Return on Equity
-114.2%
Return on Invested Capital
-100.0%
Return on Capital Employed
-117.6%
Return on Tangible Assets
-88.4%

Historical Growth (CAGR)

Revenue CAGR 3Y
-50.1%
Revenue CAGR 5Y
-36.9%
Revenue CAGR 10Y
N/A
EPS CAGR 3Y
22.9%
EPS CAGR 5Y
20.8%
EPS CAGR 10Y
N/A
FCF CAGR 3Y
-47.9%
FCF CAGR 5Y
-19.8%
FCF CAGR 10Y
N/A

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
1
EPS Growth Next 3Y
N/A
Revenue Growth Next 3Y
N/A
Earnings Date
Dec 1, 2026
EPS Estimate (next Q)
-$1.75
EPS Growth Est (next Q)
-85.7%
Revenue Est (next Q)
$12.42K
Revenue Growth Est (next Q)
521.1%

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$1
Price Target Upside
-56.7%

Cash Flow

Operating Cash Flow
$-4.79M
Free Cash Flow
$-5.04M
Adj. Free Cash Flow
$-5.12M
FCF Per Share
-$19.98
OCF Per Share
-$18.98
OCF/S Ratio
-53775.8%

Income Statement

Revenue
$12.42K
Gross Profit
$7.69K
Operating Income
$-6.4M
EBITDA
$-6.05M
Net Income
$-5.02M
EPS (Diluted)
-$16.70
Revenue / Employee
$477.81
Profit / Employee
$-193.22K
Employees
26

© 2026 bestshares.com. All rights reserved.